Cornell Researchers Developed Reversible Male Contraceptive

A six-year study demonstrated that a non-hormonal compound can safely halt and restart sperm production in mice.

Updated on Oct. 7, 2026 in Men’s Health

Cornell Researchers Developed Reversible Male Contraceptive

Live Poll

Would you consider using a reversible, non-hormonal male contraceptive if it were available?

Scientists at Cornell University have successfully used the compound JQ1 to create a reversible, non-hormonal contraceptive method in mice. The treatment effectively stopped sperm production during a three-week administration period, with full fertility returning shortly thereafter.

Why it matters

This research aims to provide a reliable, non-hormonal alternative for male contraception that avoids the side effects associated with traditional hormone-based methods. By targeting a specific stage of cell development, the technique ensures that fertility remains recoverable once the treatment stops.

The study spanned six years and utilized JQ1 to inhibit prophase I during meiosis. Treated mice successfully regained fertility and produced healthy offspring within six weeks of ceasing the three-week administration regimen.

The players

Cornell University

This private Ivy League research institution served as the primary site for the reproductive sciences study.

Cornell Reproductive Sciences Center

This department led the scientific investigation into the development of non-hormonal contraceptive methods.

Proceedings of the National Academy of Sciences

This peer-reviewed journal published the final findings regarding the mouse study.

The details

The research team at the Cornell Reproductive Sciences Center utilized JQ1, a compound previously developed for cancer and inflammatory diseases, to interrupt the meiosis stage of cell production. The method effectively silences sperm development without the systemic hormonal shifts common in other contraceptive approaches.

The research study was conducted over a period of six years.
The JQ1 contraceptive treatment was administered for three weeks.
Fertility and sperm production recovered within six weeks of ending the treatment.

The Big Picture

This study follows the path set by the Cornell Reproductive Sciences Center research pipeline to identify non-hormonal alternatives for reproductive regulation. The findings suggest a fundamental shift toward targeting specific meiotic stages rather than systemic hormonal pathways.

This development could eventually lead to new contraceptive options for men, such as a patch or injection, that avoid the side effects of hormone therapy. Future clinical trials will determine if this method is a safe and effective replacement for current birth control standards.

The takeaway

The study confirms that sperm production can be temporarily and safely paused without long-term damage to reproductive function. This paves the way for potential future human contraceptives that offer users greater flexibility and fewer systemic health risks.